Marianna De Julio-Kruithof

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 88 publications

Clinical Translation of Patient-Derived Organoids: Perspectives for Personalized Therapy in Cancer.

Clinical Translation of Patient-Derived Organoids: Perspectives for Personalized Therapy in Cancer.

Journal: International journal of cancer

Published: February 18, 2026

Expression of progranulin (GP88) protein appears as an independent prognostic factor for clinical progression in high-risk prostate cancer patients.

Expression of progranulin (GP88) protein appears as an independent prognostic factor for clinical progression in high-risk prostate cancer patients.

Journal: Scientific reports

Published: February 10, 2026

Patient-derived models of prostate cancer: Capturing tumour complexity from initiation to metastasis.

Patient-derived models of prostate cancer: Capturing tumour complexity from initiation to metastasis.

Journal: Cancer letters

Published: January 21, 2026

Correction: Editorial: Mechanisms of microenvironment governed plasticity and progression in solid tumors.

Correction: Editorial: Mechanisms of microenvironment governed plasticity and progression in solid tumors.

Journal: Frontiers in cell and developmental biology

Published: September 09, 2025

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization.

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization.

Journal: Molecular oncology

Published: July 09, 2025

Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.

Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.

Journal: Frontiers in cell and developmental biology

Published: June 25, 2025

Unraveling the YAP1-TGFβ1 axis: a key driver of androgen receptor loss in prostate cancer-associated fibroblasts.

Unraveling the YAP1-TGFβ1 axis: a key driver of androgen receptor loss in prostate cancer-associated fibroblasts.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 11, 2025

Cancer Organoids as reliable disease models to drive clinical development of novel therapies.

Cancer Organoids as reliable disease models to drive clinical development of novel therapies.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 13, 2024

xCT as a potential marker for neuroendocrine cells in high-risk prostate cancer and the relation to AL122023.1-miR-26a/30d/30e axis.

xCT as a potential marker for neuroendocrine cells in high-risk prostate cancer and the relation to AL122023.1-miR-26a/30d/30e axis.

Journal: PloS one

Published: November 13, 2024

TRPM4 contributes to cell death in prostate cancer tumor spheroids, and to extravasation and metastasis in a zebrafish xenograft model system.

TRPM4 contributes to cell death in prostate cancer tumor spheroids, and to extravasation and metastasis in a zebrafish xenograft model system.

Journal: Molecular oncology

Published: September 12, 2024

Patient-derived Organoids in Bladder Cancer: Opportunities and Challenges.

Patient-derived Organoids in Bladder Cancer: Opportunities and Challenges.

Journal: European urology focus

Published: May 24, 2024

Enhancing risk stratification models in localized prostate cancer by novel validated tissue biomarkers.

Enhancing risk stratification models in localized prostate cancer by novel validated tissue biomarkers.

Journal: Prostate cancer and prostatic diseases

Published: May 13, 2024

Showing 1-12 of 88

Last Updated: 09/26/2026